Literature DB >> 32514896

Oral Anticoagulant Utilization in the United States and United Kingdom.

Michael Colacci1,2, Eric K Tseng3, Chana A Sacks4, Michael Fralick5.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32514896      PMCID： PMC7403268          DOI： 10.1007/s11606-020-05904-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castellá; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-01

Review 2.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2019-01-28       Impact factor: 29.690

Review 3.  Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lana A Castellucci; Chris Cameron; Grégoire Le Gal; Marc A Rodger; Doug Coyle; Philip S Wells; Tammy Clifford; Esteban Gandara; George Wells; Marc Carrier
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

Review 4.  Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.

Authors:  José A López-López; Jonathan A C Sterne; Howard H Z Thom; Julian P T Higgins; Aroon D Hingorani; George N Okoli; Philippa A Davies; Pritesh N Bodalia; Peter A Bryden; Nicky J Welton; William Hollingworth; Deborah M Caldwell; Jelena Savović; Sofia Dias; Chris Salisbury; Diane Eaton; Annya Stephens-Boal; Reecha Sofat
Journal:  BMJ       Date:  2017-11-28

5.  OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998-2016.

Authors:  Helen J Curtis; Ben Goldacre
Journal:  BMJ Open       Date:  2018-02-23       Impact factor: 2.692
  5 in total
  7 in total

1.  Perioperative consultative hematology: can you clear my patient for a procedure?

Authors:  Allison Elaine Burnett; Bishoy Ragheb; Scott Kaatz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Reasons for nonadherence to the direct oral anticoagulant apixaban for atrial fibrillation.

Authors:  Derjung M Tarn; Kevin J Shih; Janice B Schwartz
Journal:  J Am Geriatr Soc       Date:  2021-08-27       Impact factor: 5.562

3.  Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.

Authors:  Cheng-Wei Huang; Lewei Duan; Jaejin An; John J Sim; Ming-Sum Lee
Journal:  J Gen Intern Med       Date:  2021-09-20       Impact factor: 6.473

4.  Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism.

Authors:  Alison R Novak; Courtney Shakowski; Toby C Trujillo; Garth C Wright; Scott W Mueller; Tyree H Kiser
Journal:  J Thromb Thrombolysis       Date:  2022-06-10       Impact factor: 5.221

5.  Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.

Authors:  Tanyanan Tanawuttiwat; Amanda Stebbins; Guillaume Marquis-Gravel; Sreekanth Vemulapalli; Andrzej S Kosinski; Alan Cheng
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 5.501

6.  Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series.

Authors:  Haroon Ahmed; Heather Whitaker; Daniel Farewell; Julia Hippisley-Cox; Simon Noble
Journal:  BMJ       Date:  2021-12-21

7.  Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding.

Authors:  Selman Uranues; Abraham Fingerhut; Eve Levin; Daniel Spazierer; Nastaran Rahimi; Bernhard Baumgartner
Journal:  BMC Surg       Date:  2022-08-14       Impact factor: 2.030
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.